Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aldosterone as a Mediator of Cardiovascular Damage
Fabrizio Buffolo, Martina Tetti, Paolo Mulatero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1899-1911
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 25
Association of the trajectory of plasma aldosterone concentration with the risk of cardiovascular disease in patients with hypertension: a cohort study
Xintian Cai, Shuaiwei Song, Junli Hu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Non-Hypertensive Effects of Aldosterone
Natalia Ekman, Ashley Grossman, Anna Nieckarz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 540-540
Open Access | Times Cited: 1
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
Jun Yang, Jacopo Burrello, Jessica Goi, et al.
The Lancet Diabetes & Endocrinology (2025)
Closed Access | Times Cited: 1
Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
Yoshimichi Takeda, Masashi Demura, Mitsuhiro Kometani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5782-5782
Open Access | Times Cited: 21
Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline
Paolo Mulatero, Ute I. Scholl, Carlos Fardella, et al.
European Journal of Endocrinology (2024) Vol. 190, Iss. 4, pp. G1-G14
Open Access | Times Cited: 7
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review
Wei‐Ting Wang, Tsung-Hui Wu, Leay‐Kiaw Er, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1103-1119
Closed Access | Times Cited: 6
Effect of finerenone on the KCCQ in patients with HFmrEF/HFpEF: A prespecified analysis of FINEARTS-HF
Mingming Yang, Alasdair Henderson, Atefeh Talebi, et al.
Journal of the American College of Cardiology (2024) Vol. 85, Iss. 2, pp. 120-136
Open Access | Times Cited: 6
Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism
Paolo Mulatero, Chiara Bertello, Franco Veglio, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 11, pp. 3175-3181
Open Access | Times Cited: 23
Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis
Sunil Samnani, Irena Cenzer, Gregory Kline, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 3, pp. e1280-e1289
Open Access | Times Cited: 14
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Nathan Mullen, James Curneen, Padraig Donlon, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 125-170
Open Access | Times Cited: 13
Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism Phenotypes
Fabrizio Buffolo, Alessio Pecori, Martín Reincke, et al.
Hypertension (2023) Vol. 81, Iss. 2, pp. 340-347
Closed Access | Times Cited: 13
The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin
Deidree V. N. Somanader, Peishen Zhao, Robert E. Widdop, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116130-116130
Open Access | Times Cited: 5
Metabolic Status and Hypertension: The Impact of Insulin Resistance-Related Indices on Blood Pressure Regulation and Hypertension Risk
Xinying Hu, Peng Han, Yong Liu
Journal of the American Nutrition Association (2025), pp. 1-11
Closed Access
Association Between Sodium- and Potassium-Related Urinary Markers and the Prevalence of Atrial Fibrillation
Sayuri Tokioka, Naoki Nakaya, Rieko Hatanaka, et al.
Circulation Journal (2025)
Open Access
The renin‐angiotensin‐aldosterone system and salt sensitivity of blood pressure offer new insights in obesity phenotypes
Yan Emily Yuan, Andrea Haas, Bernard Rosner, et al.
Obesity (2025)
Closed Access
In Vivo Investigation of the Effects of Nonylphenol on the Pituitary–Adrenal Axis and Pineal Gland in Male Rats
Eda Nur İNKAYA, E. Tokgöz, Nurhayat Barlas
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Autonomous Epinephrine Release by KCNJ5 Mutation Drives Familial Thoracic Aortic Aneurysm and Dissection
Yanyu Duan, Chenglong Wu, Zhenghong Lai, et al.
Hypertension (2025)
Closed Access
Comparison of the clinical significance of lymphocyte-based inflammatory indices between the two major subtypes of primary aldosteronism
Daisuke Watanabe, Satoshi Morimoto, Noriko Morishima, et al.
Endocrine (2025)
Closed Access
Estimated sodium intake and premature ventricular complexes: data from the population-based Swedish CArdioPulmonary bioImage Study
Johan Economou Lundeberg, Jonas Wuopio, Andrew Mente, et al.
Heart (2025), pp. heartjnl-324391
Closed Access
Hypertension and target organ damage
María Lorenza Muiesan, Giacomo Buso, S. Cappellini, et al.
Elsevier eBooks (2025)
Closed Access
CHO-S expression of a novel human recombinant IgG1 of anti-ALD antibody isolated by phage mutation display
Guilin Li, Jiazhen Liu, Zhenzhen Guan, et al.
Journal of Immunological Methods (2025), pp. 113843-113843
Closed Access
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors
Wryan Helmeczi, Gregory L. Hundemer
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Advancing surgical outcomes through cardiovascular biomarker sub-phenotyping
Bruno Garcia, Ashish K. Khanna, Matthieu Legrand
British Journal of Anaesthesia (2025)
Closed Access
Senotherapeutic approach to age-related endocrine diseases
Seda Turgut, Gülnur Andican
Advances in pharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top